Recent research has identified an association between skeletal muscle health and the risk of developing dementia, particularly focusing on sarcopenia, a condition marked by the progressive loss of muscle mass and function. While most previous studies have concentrated on older adults or those already experiencing cognitive impairment, there has been limited investigation into how muscle health relates to cognitive function in broader, middle-aged populations.
The study, published in the Journal of Cachexia, Sarcopenia and Muscle, led by Kentaro Ikeue from Doshisha University addresses this gap. The research team conducted a cross-sectional analysis of 263 Japanese adults over the age of 40, examining which measures of muscle quantity, quality, and strength best reflect cognitive decline.
The study evaluated several sarcopenia-related indices: appendicular skeletal muscle mass (ASM) adjusted for height or body mass index, handgrip strength (HGS), HGS relative to upper extremity muscle mass, and phase angle (PhA)—a bioelectrical impedance measure reflecting muscle quality and cellular integrity. Cognitive function was assessed using the Japanese version of the Montreal Cognitive Assessment (MoCA-J), which covers memory, attention, language, and executive function.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
The findings revealed that phase angle was the most significant indicator. “We found that a higher phase angle is associated with a lower risk of mild cognitive impairment in women,” said Dr. Ikeue. In both men and women, higher phase angle correlated with better memory, while in women, it was also linked to language, executive function, and attention. These results suggest sex-specific patterns in the relationship between muscle quality and cognition.
The researchers propose that routine assessment of phase angle could help identify individuals at risk for cognitive decline, allowing for early interventions. Dr. Ikeue emphasized, “Our findings suggest that phase angle is not only useful for assessing sarcopenia but also serves as a potential marker for early cognitive decline.”